Patient with recurrent glioblastoma (gbm) began optune therapy on (b)(6) 2015.On (b)(6) 2015, the patient was hospitalized due to new onset seizure.Prior to admission, patient had experienced a 20 minute episode of confusion and visual disturbance.Patient was admitted for neurological work-up and mri scan (results not provided).Optune therapy was temporarily discontinued upon admission.Ophthalmologic consultation found left lower homonymous quadrantanopia with no papilledema.Brain ct scan did not show evidence of disease progression.Patient was treated with levetiracetam 500 mg bid and dexamethasone dose was increased to 6 mg daily.Patient improved with no further seizure activity.Patient was discharged on (b)(6) 2015 and optune therapy was restarted.Per the prescribing physician, the events were the results of an epileptiform attack related to the patient's underlying gbm.
|